Глобальный рынок лечения спастичности – тенденции отрасли и прогноз до 2029 года

Анализ рынка и идеи Глобальный рынок лечения спастичности

Прогнозируется, что объем рынка лечения спастичности будет расти с годовым темпом прироста 10,1% в прогнозируемый период с 2022 по 2029 год. Отчет Data Bridge Market Research о рынке лечения спастичности содержит анализ и информацию о различных факторах, которые, как ожидается, будут преобладать в течение прогнозируемого периода, а также описывает их влияние на рост рынка.

Спастичность — это в основном расстройство мышц, которое обычно характеризуется постоянным сокращением мышц, вызывающим напряженные или жесткие мышцы и приводящим к неспособности контролировать эти мышцы. Симптомы этого расстройства включают сверхактивные рефлексы, повышенный мышечный тонус, спазмы, ненормальную позу и клонус. Оно вызывает повреждения тканей головного или спинного мозга, которые контролируют произвольные движения, что приводит к дисбалансу сигналов между нервной системой и произвольными мышцами. Оно отрицательно влияет на мышцы и суставы конечностей и очень вредно для растущих детей.

Ожидается, что растущая популярность физиотерапии среди населения и во всем мире ускорит рост рынка в прогнозируемый период с 2022 по 2029 год. Кроме того, ряд преимуществ, связанных с физиотерапией, побуждают различные больницы инвестировать в физиотерапевтические центры, что еще больше проложит путь для роста рынка. Ожидается, что разработка стимулирующих устройств, встроенных в передовые технологии, и рост расходов на программы общественного здравоохранения будут способствовать общему росту рынка. Однако недостаточная осведомленность людей о спастичности в развивающихся странах также препятствует общему росту рынка. Более того, неблагоприятные эффекты, связанные с принимаемыми препаратами, также, как ожидается, будут ограничивать общий рост рынка.

In addition, increasing global healthcare expenditure, launch of novel therapeutics, rising per capita income in emerging markets and the time required to gain results of physical therapy are likely to create various new opportunities that will impact this spasticity treatment market growth in the forecast period of 2022 to 2029. On the flip side, the inadequate reimbursement and lack of availability of skilled professionals is estimated to challenge the market’s growth.

This spasticity treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the spasticity treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Spasticity Treatment Market Scope and Market Size

Spasticity treatment market is segmented on the basis of therapy, treatment, drugs, route of administration, indication, distribution channel and end-users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of therapy, the spasticity treatment market is segmented as physical therapy and occupational therapy.
• On the basis of treatment, the spasticity treatment market is segmented as medication and surgery.
• On the basis of drugs, the spasticity treatment market is segmented as baclofen, dantrolene sodium, gabapentin and others.
• On the basis of route of administration, the spasticity treatment market is segmented into oral, intramuscular and others.
• On the basis of indication, the spasticity treatment market is segmented as multiple sclerosis (MS), cerebral palsy (CP), traumatic brain injury (TBI) and others.
• On the basis of distribution channel, the spasticity treatment market is segmented as hospital pharmacy, online pharmacy and retail pharmacy.
• Based on end-users, the spasticity treatment market is segmented into hospitals, homecare, specialty clinics and others.

Spasticity Treatment Market Country Level Analysis

Spasticity treatment market is segmented on the basis of therapy, treatment, drugs, route of administration, indication, distribution channel and end-users.

The countries covered in the spasticity treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the spasticity treatment market due to the increasing levels of investment for the development of advanced technologies such as cryotherapy, revascularization, cardiogenic shock and others in this region. Asia-Pacific region, on the other hand is expected to expand at a significant growth rate because of the increasing population along with advancement of healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Spasticity treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Spasticity Treatment Market Share Analysis

Spasticity treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to spasticity treatment market.

Некоторые из основных игроков, работающих в отчете о рынке лечения спастичности, включают F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Medtronic, ALLERGAN, Pfizer Inc, Ipsen Pharma, UCB Pharma Ltd, Sanofi, INMED PHARMACEUTICALS INC, Orient Pharma, Taj Pharmaceuticals Limited, Johnson & Johnson Services, Inc., MediciNova, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Merz Pharma, GW Pharmaceuticals plc, Revance Therapeutics, Inc и Acorda Therapeutics, Inc., а также другие.

SKU-50493